You Position: Home > Paper
Advances in the susceptibility testing of Sporothrix schenckii and treatment of sporotrichosis
( views:396, downloads:166 )
- Author:
- No author available
- Journal Title:
- INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
- Issue:
- 1
- DOI:
- 10.3760/cma.j.issn.1673-4173.2010.01.007
- Key Word:
- 孢子丝菌病;孢子丝菌属;微生物敏感性试验;治疗;Sporotrichosis;Sporotrix;Microbial sensitivity tests;Treatment
Abstract： Spomtrichosis is a subcutaneous infection caused by Sporothrix schenckii,a dimorphic fungus.No unified standard is available at present for in vitro susceptibility testing of dimorphie fungi.Ahhoush saturated solution of potassium iodide.itraconazole and terbinafine have been commonly used in the treatment of sporotrichosis for many years,it is still essential to choose appropriate antifungals.In vitro susceptibility test is not only an important means to the estimate of antifungal activity but also a basis for drug selection.
- [1]A, Ghosh,A, Chakrabarti,B M, Hemashettar,etc.In vitro susceptibility pattern of Sporothrix schenckii strains isolated from three centers in India.[J].2001,113.
- [2]Alvarado-Ramirez E,Torres-Rodriguez JM.In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.[J].2007,51(7).
- [3]Kohler LM,Hamdan JS,Ferrari TC.Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing.[J].2007,58(1).
- [4]Ana Raquel Mano, Meinerz,Patrícia da Silva, Nascente,Luiz Filipe Damé, Schuch,etc.[In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole].[J].1900,40(1).
- [5]Da-Silva-Barros ME,Hamdan JS,Kohler LM,etc.In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms.[J].2006,52(9).
- [6]Marimon R,Cano J,Gene J,etc.In vitro antifungal susceptibilities of five species of sporothrix.[J].2008,52(2).
- [7]Ana Cecília Michel da Rosa,Maria Lúcia Scroferneker,Rodrigo Vettorato,etc.Epidemiology of sporotrichosis: A study of 304 cases in Brazil[J].2005,52(3).
- [8]Saul A,Fierro L,Ponce RM,etc.Cutaneous sporotrichosis. Intermittent treatment (pulses) with itraconazole.[J].2008,18(1).
- [9]Uno J,Nakai T,Nishimura K,etc.In Vitro Antifungal Activity of Micafungin (FK463) against Dimorphic Fungi: Comparison of Yeast-Like and Mycelial Forms.[J].2003,47(4).
- [10]Bakshi R,Emady Azar S,Dietze R,etc.Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.[J].2004,47(1).
- [11]de Almeida Paes R,Inza I,Fernandez Torres B,etc.In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases.[J].2005,49(9).
- [12]Cuenca Estrella M,Gutierrez Galhardo MC,Zancope Oliveira RM,etc.Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test.[J].2010,53(3).
- [13]Hamdan JS,Hahn RC,Kohler LM,etc.In Vitro Susceptibilities of Isolates of Sporothrix schenckii to Itraconazole and Terbinafine.[J].2004,42(9).
- [14]Marimon R,Cano J,Gene J,etc.Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest.[J].2007,45(10).
- [15]Ruiz-Cendoya M,Rodriguez MM,Marine M,etc.In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi[J].2008,32(5).
- [16]Nordoff N,Warnock DW,McGinnis MR,etc.Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.[J].2001,39(4).
- [17]De-Oliveira RM,Mellado E,Rodriguez-Tudela JL,etc.Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil.[J].2008,46(2).